ANIMAL HEALTH NEWS-January 2022

ANIMAL HEALTH HEADLINES JANUARY

Political changes in LATIN AMERICA can occur during 2022 in Chile, Colombia and Brazil. Intermedica in Argentina gathered over 400 Veterinarians in their recent event in Buenos Aires. New launches of some companies in the US and some techological start ups related to ANIMAL HEALTH innovative projects are leading the news of the year start.

?? Elections 2022 in Latin America: The result of the elections to be held this year could consolidate the ideological shift that has been taking place in the region. The economic, political and social discontent that was observed in countries such as Chile, Colombia and Brazil, was increased by the effects of the pandemic and this inertia is likely to persist. (Political Animal, Jan 12th 2022)

?? It was approved a kit to evaluate the quality of veterinary vaccines in Argentina: Motivar, 14 January, 2022. Marina Bock. "Achieving that the Argentinean vaccines against IBR had a potency data was a very important break for the country's animal health." It is an Elisa test that measures the amount of antibodies induced by the IBR vaccine. It was developed by Incuinta, approved by Senasa and allows companies to improve their production processes. Infectious Bovine Rhinotracheitis (IBR) is a contagious disease of cattle caused by Herpesvirus type 1 (BoHV-1).

?? Editorial Intermédica summoned almost 400 professionals dedicated to companion animals to the first edition of a meeting where opinion leaders took part in two days with a wide variety of topics related to the profession. (Motivate, Jan 2022). On December 5 and 6, the “X-VET – El reencuentro” congress was held, an activity organized by Editorial Intermédica in Parque Norte, the Autonomous City of Buenos Aires.

?? PetMedix announced a collaboration with Zoetis to develop novel, fully species-specific companion animal monoclonal antibody therapeutics using PetMedix's proprietary Ky9 and Felyne transgenic platforms. (company press release)

?? Argentinean Laboratory Tecnofarm recently opened a new Logistical Operations Center in the district of San Martín (Big Buenos Aires). “60% of the units produced in our plant located in Villa Lynch during the past year were marketed under the Tecnofarm brand, while the remaining 40% were produced for third-party laboratories that, in addition to participating in the internal market, they export their products to countries where they are required to produce in a plant with the official GMP certification of Senasa, like ours”

?? The FDA announced it has approved Zoetis ' Solensia (frunevetmab injection), the first treatment for the control of pain associated with osteoarthritis in cats and the first monoclonal antibody (mAb) new animal drug approved by the FDA for use in any animal species. (FDA)

?? Dechra announced a joint collaboration with Bioiberica for the license and distribution of its Atopivet range of dermatology products for cats and dogs in the US. The partnership includes the products Atopivet Collar, Atopivet Spot-On, and Atopivet Mousse. (company press release)

?? BRAZIL Ouro Fino Saude Animal SA announced that state development bank BNDES has hired BTG Pactual to seek investors to buy its stake in the company. The bank's 12.26% stake in the company is worth roughly R$167 million ($29.4 million). (Reuters). Ourofino Animal Health was recently recognized with the Most Integrity Seal from the Ministry of Agriculture: The award took into account aspects such as the concern with protecting the health and welfare of animals, with the quality and hygienic-sanitary safety of food and other agricultural products, suitability of inputs and services used in agriculture.

?? Stefan Mihailov is the new president of Champion Saúde Animal: From Monday (17), the position of president of Champion, a Brazilian animal nutrition and health company, based in Anápolis (GO), will be held by veterinarian Stefan Mihailov, 55 years old . The announcement was made today (13), by Flavio Alves da Rocha, current president who will pass to the board of directors. “Champion is prepared to take an audacious leap”, says Rocha.

?? TEANECK, NJ, January 12, 2022--(BUSINESS WIRE)--Phibro Animal Health Corporation (NASDAQ:PAHC): Today, the Food and Drug Administration (FDA) provided notice in the Federal Register of its intention to hold a public hearing regarding Mecadox? (carbadox). Mecadox has been approved and sold in the United States for 50 years and is a widely used treatment for controlling bacterial diseases in swine, including Salmonella and swine dysentery, resulting in improved health and welfare for newly born and young pigs.

?? FARMINGDALE, NY, Jan. 12, 2022 /PRNewswire/ -- Codagenix, Inc. a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic virus therapies, today announced the appointment of Bruce E. Taillon, Ph.D. , as Executive Vice President of Animal Health. A recognized leader in the animal health biopharmaceutical space, Taillon brings more than two decades of experience and thought leadership in disease management, including infectious and inflammatory disease and oncology, across diverse animal species.

?? EU?Covetrus announced a new organizational structure within Northern and Central Europe. Critical changes include the development of a new International leadership team and a collaborative focus within the UK and German businesses. (company press release)

?? TECHNOLOGY: Invoxia Telecommunications (GPS Trackers) announced plans to launch of a Smart Dog Collar that includes GPS tracking and health monitoring. (zdnet.com). In addition, the CES show in Las Vegas last week showcased a number of new consumer electronics to watch for in 2022, including a few surprises for pet owners. Two new products include the Bird Buddy smart bird feeder and Samsung's Petnow app, which helps locate and identify pets via nose print rather than implanted microchips. (Pet Products Smartbrief - CNN).

?? Virbac started to build a global center of excellence for biological products at its headquarters in Carros, France as part of a transformation plan. Virbac will also set up a biology academy to develop its employees’ skills, particularly in industrial engineering, biological technology platforms and sterility control in industrial environments. The company’s project is being backed by the French government’s stimulus plan to support industrial investment programs in six strategic sectors. Virbac has been awarded a EUR 900,000 ($1.02 million) grant through the plan and a supplemental EUR 500,000 grant from the region. (IHS Markit Connect)

?? Vetoquinol USA announced that Imoxi (generic imidacloprid moxidectin) Topical Solution for Cats is now available. This follows the launch of the canine product of the same name in 2021. (company press release)

?? Dechra Pharmaceuticals PLC announced the acquisition of the veterinary approved Isoflurane, USP Inhalant Anesthetic and Sevoflurane, USP Inhalant Anesthetic from Halocarbon Life Sciences. Dechra will be launching the veterinary branded Isoflurane and Sevoflurane in the first quarter of 2022. (company press release). They also informed it has agreed terms with Anivive Lifesciences, Inc. to acquire the worldwide rights to Laverdia-CA1 (verdinexor), a novel treatment of all forms and stages of canine lymphoma in dogs. The drug was conditionally approved by the FDA Center for Veterinary Medicine on January 11, 2021. Dechra is also buying a first right of refusal for other species along with the trademark. Financial terms were not disclosed. (Nasdaq.com).

BERNARDO OTERO (Ceo & Founder NEXUS ANIMAL HEALTH)

?

?